Nuwellis Inc (NUWE) - Total Assets
Based on the latest financial reports, Nuwellis Inc (NUWE) holds total assets worth $7.98 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Nuwellis Inc (NUWE) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Nuwellis Inc - Total Assets Trend (2002–2024)
This chart illustrates how Nuwellis Inc's total assets have evolved over time, based on quarterly financial data. See Nuwellis Inc net assets for net asset value and shareholders' equity analysis.
Nuwellis Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Nuwellis Inc's total assets of $7.98 Million consist of 89.8% current assets and 10.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 51.7% |
| Accounts Receivable | $1.73 Million | 17.5% |
| Inventory | $1.72 Million | 17.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2002–2024)
This chart illustrates how Nuwellis Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Nuwellis Inc (NUWE) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nuwellis Inc's current assets represent 89.8% of total assets in 2024, a decrease from 92.6% in 2002.
- Cash Position: Cash and equivalents constituted 51.7% of total assets in 2024, down from 91.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is accounts receivable at 17.5% of total assets.
Nuwellis Inc Competitors by Total Assets
Key competitors of Nuwellis Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.78 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.02 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
Nuwellis Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.04 | 2.03 | 5.17 |
| Quick Ratio | 1.42 | 1.34 | 4.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.68 Million | $2.79 Million | $14.95 Million |
Nuwellis Inc - Advanced Valuation Insights
This section examines the relationship between Nuwellis Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.33 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 1.0% |
| Total Assets | $9.86 Million |
| Market Capitalization | $2.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nuwellis Inc's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nuwellis Inc's assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nuwellis Inc (2002–2024)
The table below shows the annual total assets of Nuwellis Inc from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $9.86 Million | +0.96% |
| 2023-12-31 | $9.77 Million | -60.40% |
| 2022-12-31 | $24.67 Million | -18.88% |
| 2021-12-31 | $30.42 Million | +51.99% |
| 2020-12-31 | $20.01 Million | +257.23% |
| 2019-12-31 | $5.60 Million | -36.17% |
| 2018-12-31 | $8.78 Million | -52.45% |
| 2017-12-31 | $18.45 Million | +147.02% |
| 2016-12-31 | $7.47 Million | -69.59% |
| 2015-12-31 | $24.57 Million | -24.10% |
| 2014-12-31 | $32.37 Million | -41.39% |
| 2013-12-31 | $55.23 Million | +267.32% |
| 2012-12-31 | $15.04 Million | +102.34% |
| 2011-12-31 | $7.43 Million | +66.06% |
| 2010-12-31 | $4.47 Million | 0.00% |
| 2009-12-31 | $4.47 Million | +125.67% |
| 2008-12-31 | $1.98 Million | -79.64% |
| 2007-12-31 | $9.74 Million | +36.98% |
| 2006-12-31 | $7.11 Million | +49.65% |
| 2005-12-31 | $4.75 Million | -37.83% |
| 2004-12-31 | $7.64 Million | +442.13% |
| 2003-12-31 | $1.41 Million | +9.80% |
| 2002-12-31 | $1.28 Million | -- |
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The compan… Read more